Cataloging Antineoplastic Agents According to Their Effectiveness Against Platinum-resistant and Platinum-sensitive Ovarian Carcinoma Cell Lines

Overview

Journal J Transl Sci

Publisher Open Access Text

Date 2016 Apr 15

PMID 27076919

Citations 5

Authors

Kimiko Ishiguro

Yong-Lian Zhu

Z Ping Lin

Philip G Penketh

Krishnamurthy Shyam

Rui Zhu

Raymond P Baumann

Alan C Sartorelli

Thomas J Rutherford

Elena S Ratner

Affiliations

Soon will be listed here.

Abstract

Although epithelial ovarian cancers (EOCs) are initially treated with platinum-based chemotherapy, EOCs vary in platinum responsiveness. Cataloging antineoplastic agents according to their effectiveness against platinum-resistant and platinum-sensitive EOC cell lines is valuable for development of therapeutic strategies to avoid platinum inefficacy and to exploit platinum sensitivity. TOV-21G devoid of FANCF expression, OV-90 and SKOV-3 were employed as examples of platinum-sensitive, platinum-intermediate and platinum-resistant cell lines, respectively. Antineoplastic agents examined included mitomycin C, doxorubicin, etoposide, gemcitabine, chlorambucil, paclitaxel, triapine and X-rays. Their effectiveness against cell lines was analyzed by clonogenic assays. Cytotoxic profiles of mitomycin C and carboplatin were similar, with mitomycin C exhibiting greater potency and selectivity against TOV-21G than carboplatin. Cytotoxic profiles of doxorubicin, etoposide and X-rays overlapped with that of carboplatin, while OV-90 overexpressing Rad51 was more resistant to chlorambucil than SKOV-3. The efficacy of paclitaxel and triapine was independent of platinum sensitivity or resistance. Consistent with these cytotoxic profiles, cisplatin/mitomycin C, triapine, and paclitaxel differed in the capacity to induce phosphorylation of H2AX, and produced unique inhibitory patterns of DNA/RNA syntheses in HL-60 human leukemia cells. Paclitaxel and triapine in combination produced additive antitumor effects in M109 murine lung carcinoma. In conclusion, mitomycin C is potentially more effective against Fanconi anemia pathway-deficient EOCs than carboplatin. Doxorubicin and etoposide, because of their overlapping cytotoxic properties with carboplatin, are unlikely to be efficacious against platinum-refractory EOCs. Paclitaxel and triapine are effective regardless of platinum sensitivity status, and promising in combination for both platinum-sensitive and platinum-refractory EOCs.

Citing Articles

Metformin Affects Olaparib Sensitivity through Induction of Apoptosis in Epithelial Ovarian Cancer Cell Lines.

Gralewska P, Gajek A, Marczak A, Rogalska A Int J Mol Sci. 2021; 22(19).

PMID: 34638899 PMC: 8508816. DOI: 10.3390/ijms221910557.

Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models.

Brodeur M, Simeone K, Leclerc-Deslauniers K, Fleury H, Carmona E, Provencher D Sci Rep. 2021; 11(1):18183.

PMID: 34521878 PMC: 8440566. DOI: 10.1038/s41598-021-97434-w.

MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells.

Zanotti S, Vanhauwaert S, Van Neste C, Olexiouk V, Van Laere J, Verschuuren M Sci Rep. 2021; 11(1):14454.

PMID: 34262099 PMC: 8280219. DOI: 10.1038/s41598-021-93863-9.

ONC201 induces the unfolded protein response (UPR) in high- and low-grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity.

Rumman M, Buck S, Polin L, Dzinic S, Boerner J, Winer I Cancer Med. 2021; 10(10):3373-3387.

PMID: 33932119 PMC: 8124100. DOI: 10.1002/cam4.3858.

Three-Dimensional Cellular Arrangement in Epithelial Ovarian Cancer Cell Lines TOV-21G and SKOV-3 is Associated with Apoptosis-Related miRNA Expression Modulation.

de Lima A, Silva L, Goncales N, Carvalho M, Filho A, da Conceicao Braga L Cancer Microenviron. 2018; 11(1):85-92.

PMID: 29307001 PMC: 6008266. DOI: 10.1007/s12307-017-0203-z.

References

Rafnar T, Gudbjartsson D, Sulem P, Jonasdottir A, Sigurdsson A, Jonasdottir A . Mutations in BRIP1 confer high risk of ovarian cancer. Nat Genet. 2011; 43(11):1104-7. DOI: 10.1038/ng.955. View

Ishiguro K, Zhu Y, Shyam K, Penketh P, Baumann R, Sartorelli A . Quantitative relationship between guanine O(6)-alkyl lesions produced by Onrigin™ and tumor resistance by O(6)-alkylguanine-DNA alkyltransferase. Biochem Pharmacol. 2010; 80(9):1317-25. PMC: 2950702. DOI: 10.1016/j.bcp.2010.07.022. View

Finch R, Liu M, Grill S, Rose W, LOOMIS R, Vasquez K . Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity. Biochem Pharmacol. 2000; 59(8):983-91. DOI: 10.1016/s0006-2952(99)00419-0. View

Rose W . Evaluation of Madison 109 lung carcinoma as a model for screening antitumor drugs. Cancer Treat Rep. 1981; 65(3-4):299-312. View

Berglind H, Pawitan Y, Kato S, Ishioka C, Soussi T . Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination. Cancer Biol Ther. 2008; 7(5):699-708. DOI: 10.4161/cbt.7.5.5712. View

Candido-Dos-Reis F, Song H, Goode E, Cunningham J, Fridley B, Larson M . Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer. Clin Cancer Res. 2014; 21(3):652-7. PMC: 4338615. DOI: 10.1158/1078-0432.CCR-14-2497. View

Turinetto V, Giachino C . Multiple facets of histone variant H2AX: a DNA double-strand-break marker with several biological functions. Nucleic Acids Res. 2015; 43(5):2489-98. PMC: 4357700. DOI: 10.1093/nar/gkv061. View

Taniguchi T, Tischkowitz M, Ameziane N, Hodgson S, Mathew C, Joenje H . Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med. 2003; 9(5):568-74. DOI: 10.1038/nm852. View

Gruppi F, Hejazi L, Christov P, Krishnamachari S, Turesky R, Rizzo C . Characterization of nitrogen mustard formamidopyrimidine adduct formation of bis(2-chloroethyl)ethylamine with calf thymus DNA and a human mammary cancer cell line. Chem Res Toxicol. 2015; 28(9):1850-60. PMC: 4579055. DOI: 10.1021/acs.chemrestox.5b00297. View

10.

Di Pasqua A, Kerwood D, Shi Y, Goodisman J, Dabrowiak J . Stability of carboplatin and oxaliplatin in their infusion solutions is due to self-association. Dalton Trans. 2011; 40(18):4821-5. DOI: 10.1039/c0dt01758b. View

11.

Liu M, Lin T, Sartorelli A . Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone. J Med Chem. 1992; 35(20):3672-7. DOI: 10.1021/jm00098a012. View

12.

Tomasz M . Mitomycin C: small, fast and deadly (but very selective). Chem Biol. 1995; 2(9):575-9. DOI: 10.1016/1074-5521(95)90120-5. View

13.

Ishiguro K, Lin Z, Penketh P, Shyam K, Zhu R, Baumann R . Distinct mechanisms of cell-kill by triapine and its terminally dimethylated derivative Dp44mT due to a loss or gain of activity of their copper(II) complexes. Biochem Pharmacol. 2014; 91(3):312-22. PMC: 4163625. DOI: 10.1016/j.bcp.2014.08.006. View

14.

Kim H, DAndrea A . Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev. 2012; 26(13):1393-408. PMC: 3403008. DOI: 10.1101/gad.195248.112. View

15.

Neuhausen S, Marshall C . Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res. 1994; 54(23):6069-72. View

16.

Ceccaldi R, OConnor K, Mouw K, Li A, Matulonis U, DAndrea A . A unique subset of epithelial ovarian cancers with platinum sensitivity and PARP inhibitor resistance. Cancer Res. 2015; 75(4):628-34. PMC: 4416405. DOI: 10.1158/0008-5472.CAN-14-2593. View

17.

Fugger K, Chu W, Haahr P, Nedergaard Kousholt A, Beck H, Payne M . FBH1 co-operates with MUS81 in inducing DNA double-strand breaks and cell death following replication stress. Nat Commun. 2013; 4:1423. DOI: 10.1038/ncomms2395. View

18.

Hucl T, Rago C, Gallmeier E, Brody J, Gorospe M, Kern S . A syngeneic variance library for functional annotation of human variation: application to BRCA2. Cancer Res. 2008; 68(13):5023-30. PMC: 2536704. DOI: 10.1158/0008-5472.CAN-07-6189. View

19.

Marteijn J, Lans H, Vermeulen W, Hoeijmakers J . Understanding nucleotide excision repair and its roles in cancer and ageing. Nat Rev Mol Cell Biol. 2014; 15(7):465-81. DOI: 10.1038/nrm3822. View

20.

. Integrated genomic analyses of ovarian carcinoma. Nature. 2011; 474(7353):609-15. PMC: 3163504. DOI: 10.1038/nature10166. View